Cardiac study used as source for new guidelines on treating people undergoing coronary artery bypass surgery

May 24, 2013

Cardiac research from the University of Alberta had serious impact as a source for the American College of Cardiology and the American Heart Association's new guidelines on how to treat patients undergoing coronary artery bypass graft surgery.

Michael Zaugg, Eliana Lucchinetti and Barry Finegan with the U of A's Faculty of Medicine & Dentistry have shown that a new treatment done with patients just before surgery may not be as beneficial as once thought.

Previous research has shown that volatile anesthetics, when paired with an opiate as sedation for , are extremely protective of the heart because they activate the organ's own protection mechanisms. Just recently, a new treatment was added to the list, which sees physicians put a blood-pressure cuff around the leg or arm to restrict blood flow in the area, allowing a number of molecules to accumulate in the area. When the cuff is released, those agents get into the bloodstream and move to the heart, where they induce protection. This process is called remote ischemic preconditioning.

"I think there is significant interference between these treatments, and it doesn't really help to add more," said Zaugg. "It may also have some side-effects because these people sometimes already have problems with perfusion [lack of blood flow] of their legs, so it may cause damage too."

For the study, the researchers collected cardiac tissue samples at the Mazankowski Alberta Heart Institute. Zaugg and Lucchinetti measured the gene expression of the entire patient's genome, and also measured biomarkers that are important in cardiac function and the inflammatory response. The study was published in the journal Anesthesiology in 2012.

The American College of Cardiology and the used this study, along with Zaugg's previous work and others' research, to help develop guidelines for treatment.

"We are proud to be part of these endeavours and we contributed significantly to the release of the guidelines," said Zaugg. "We had a lot of great feedback for this work."

His work will now focus on how volatile anesthetics affect or interfere with stem cells in the .

Explore further: Study examines exercise testing in asymptomatic patients after coronary revascularization

Related Stories

Recommended for you

Artificial heart design features porous plastic foam

October 2, 2015

Artificial hearts with multiple moving parts increase the chance of failure; scientists have worked up a device which is a single piece. No less interesting is the material they used; the team is taking a page out of soft ...

What powers the pumping heart?

September 25, 2015

Researchers at the Ted Rogers Centre for Heart Research have uncovered a treasure trove of proteins, which hold answers about how our heart pumps—a phenomenon known as contractility.

Sticky gel helps stem cells heal rat hearts

September 24, 2015

A sticky, protein-rich gel created by Johns Hopkins researchers appears to help stem cells stay on or in rat hearts and restore their metabolism after transplantation, improving cardiac function after simulated heart attacks, ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.